In addition, main lymphocyte subsets involved in anti-tumor immunity, including CD4+ memory T cell, CD4+ Tcm, CD8+ T cell, DC, Macrophages, Mast cell, NKT cell, and Tregs were significantly increased in the low-risk subgroup (Figure 7B). This evidence concerns the gene CD8A and neoplasm.